Recruiting Ankylosing Spondylitis Studies in Frankfurt Am Main
Open-Label Extension of EryDex Study IEDAT-04-2022
This is an international, multi-center, prospective, open-label, non-comparative study to provide EryDex treatment to ataxia telangiectasia (A-T) patients who complete the IEDAT-04-2022 trial on the n...
A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis
The purpose of this study is to evaluate the effect of bimekizumab on gene expression biomarkers at Week 48 in a subset of study participants with moderate to severe plaque psoriasis (PSO) and moderat...
About Ankylosing Spondylitis Clinical Trials in Frankfurt Am Main
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Frankfurt Am Main, HESSE. These studies are seeking a combined 196 participants. Research is being sponsored by Quince Therapeutics S.p.A., UCB Biopharma SRL. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Frankfurt Am Main — FAQ
Are there ankylosing spondylitis clinical trials in Frankfurt Am Main?
Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Frankfurt Am Main, HESSE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Frankfurt Am Main?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Frankfurt Am Main research site will contact you about next steps.
Are clinical trials in Frankfurt Am Main free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Frankfurt Am Main studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 2 active trials in Frankfurt Am Main are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov